Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 17 - The Real Truth

Unilever won't top $68B bid for GSK consumer healthcare unit

Unilever, the maker of Vaseline skin care products and Dove soap, says it won’t increase a 50 billion-pound ($68.2 billion) offer for GlaxoSmithKline’s consumer healthcare unit that was rejected last week

The Independent UK

Unilever vows not to increase GSK bid

Unilever has effectively ruled out a fourth takeover approach for GlaxoSmithKline’s consumer healthcare business after vowing not to increase its offer.

Evening Standard

GSK’s top scientist jumps ship in new blow for pharmaceutical firm

Hal Barron to leave just as pressure builds on GSK to come up with new medicines

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

UK inflation jumps to 30-year high of 5.4% as cost of living crisis deepens – as it happened

Food prices, furniture, clothes and housing costs rise; unions urge government to tackle cost of living crisis as pressure builds for February rate hike

The Guardian - UK

Little ingenuity needed to spot the weakness of THG

The value of the e-commerce firm’s ‘end-to-end technology solutions’ doesn’t seem clear – no wonder investors went cold

The Guardian - UK

Unilever ‘could lose credit rating’ with purchase of GSK consumer arm

Deal could swell Unilever’s debt pile, says ratings agency Fitch

The Guardian - UK

Unilever’s bid for GSK consumables isn’t quite the shocker it seems

This could be a long campaign and, despite all the difficulties, there is a logic to the proposal

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Unilever punished by City for failed £50bn tilt at GSK

A PROPOSED fire-sale of under-performing food assets failed to stem the blood-letting at Unilever today as the City issued a damning verdict over its failed £50 billion tilt at GlaxoSmithKline.

Evening Standard

Unilever to expand health and beauty business after failed GSK approach

Dove soap maker’s shares are biggest faller on FTSE 100 after offer for consumer products arm is rebuffed

The Guardian - UK

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.